Literature DB >> 19758744

XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.

Jia-jia Ma1, Bi-liang Chen, Xiao-yan Xin.   

Abstract

OBJECTIVE: XIAP is one of the most important members of the inhibitors of apoptosis family. It is upregulated in various malignancies, including human ovarian carcinomas, it promotes invasion, metastasis, growth, and survival of malignant cells, and it also confers resistance to some chemotherapeutic drugs. We observed the effect of XIAP gene RNA interference (RNAi) on the proliferation, apoptosis, tumorigenicity, and chemosensitivity of the human ovarian carcinoma cells A2780/cp70. STUDY
DESIGN: We used a human U6 promoter-driven DNA template approach to induce short hairpin RNA-triggered RNAi to block XIAP gene expression in the human ovarian cancer cell line A2780/cp70. A corresponding site-mutated vector was constructed as a negative control (pSilencer 2.1-NC). The expression of XIAP mRNA and protein among the stable transfected cells and the untransfected ones was detected by RT-PCR and Western blotting. The cell growth was examined and drug sensitivity was assayed using the MTT assay. Cell apoptosis was measured by flow cytometry and the tumorigenicity by using nude mice.
RESULTS: Three stable transfected cell lines: A2780/cp70-s2, A2780/cp70-NC, and A2780/cp70-neo were established. The expression levels of XIAP gene mRNA and protein in A2780/cp70-s2 were 63.3% and 60.8%, lower than in A2780/cp70-NC, A2780/cp70-neo, and untransfected A2780/cp70 cells. The cell proliferation of A2780/cp70-s2 was reduced by up to 62.2+/-1.9%. Compared with the other cell lines, the changes in apoptotic rate in A2780/cp70-s2 was 31.1+/-1.3%, obviously increasing (P<0.05). The knockdown of XIAP retards tumorigenicity in nude mice and after 21 days the average tumor weight of the A2780/cp70-s2 group was lower by 1.62+/-0.11g (P<0.05). And the survival index in A2780/cp70-s2 cells was markedly reduced with the addition of 1 microM and 10 microM cisplatinum, respectively (P<0.05).
CONCLUSIONS: XIAP gene RNAi inhibited the proliferation of ovarian carcinoma cells and caused cells to be more sensitive to cisplatin through the reduction of its mRNA and protein. These results suggest that XIAP is an ovarian cancer-related gene and that XIAP is a potential target for therapeutic anti-cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758744     DOI: 10.1016/j.ejogrb.2009.06.011

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  18 in total

1.  AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer.

Authors:  Melissa K Brunckhorst; Dimitry Lerner; Shaomeng Wang; Qin Yu
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

2.  Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.

Authors:  Yayoi Kinoshita; Tamara Kalir; Jamal Rahaman; Peter Dottino; D Stave Kohtz
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

3.  Co-expression of XIAP and CIAP1 Play Synergistic Effect on Patient's Prognosis in Head and Neck Cancer.

Authors:  Xi-Hu Yang; Liu Liu; Yong-Jie Hu; Ping Zhang; Qin-Gang Hu
Journal:  Pathol Oncol Res       Date:  2018-11-12       Impact factor: 3.201

4.  HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation.

Authors:  Xiaoping He; Ashwani Khurana; Jacie L Maguire; Jeremy Chien; Viji Shridhar
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

5.  Assessment of XAF1 as A Biomarker to Differentiate Hepatocellular Carcinoma from Nonneoplastic Liver Tissues.

Authors:  Ying Lin; Wei Li
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

6.  X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis.

Authors:  Zipeng Cao; Ruowen Zhang; Jingxia Li; Haishan Huang; Dongyun Zhang; Jingjie Zhang; Jimin Gao; Jingyuan Chen; Chuanshu Huang
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

7.  UCHL1 Is a Putative Tumor Suppressor in Ovarian Cancer Cells and Contributes to Cisplatin Resistance.

Authors:  Chengmeng Jin; Wei Yu; Xiaoyan Lou; Fan Zhou; Xu Han; Na Zhao; Biaoyang Lin
Journal:  J Cancer       Date:  2013-09-27       Impact factor: 4.207

8.  X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary.

Authors:  M Miyamoto; M Takano; K Iwaya; N Shinomiya; M Kato; T Aoyama; N Sasaki; T Goto; A Suzuki; J Hitrata; K Furuya
Journal:  Br J Cancer       Date:  2014-05-22       Impact factor: 7.640

9.  MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP.

Authors:  Yingxin Pang; Hongluan Mao; Liang Shen; Zhe Zhao; Ruihan Liu; Peishu Liu
Journal:  Onco Targets Ther       Date:  2014-04-23       Impact factor: 4.147

10.  Up-regulation of tumor necrosis factor superfamily genes in early phases of photoreceptor degeneration.

Authors:  Sem Genini; William A Beltran; Gustavo D Aguirre
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.